Home > > > > Report Detail

Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 05-Sep-2022
No. of pages: 83
Inquire Before Buying

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Subcutaneous Immunoglobulins market is projected to reach US$ 9807.2 million by 2028 from an estimated US$ 4953.9 million in 2022, at a CAGR of 12.1% during 2023 and 2028.

In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.

South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.

In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Immunoglobulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Subcutaneous Immunoglobulins.

The Subcutaneous Immunoglobulins market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Subcutaneous Immunoglobulins market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Subcutaneous Immunoglobulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Shire (Baxalta)

- Grifols

- CSL

Product Type Insights

Global markets are presented by Subcutaneous Immunoglobulins purity, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Subcutaneous Immunoglobulins are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by purity, and during the historical period (2017-2022) and forecast period (2023-2028).

Subcutaneous Immunoglobulins Segment by Purity

- 0.1

- 0.2

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Subcutaneous Immunoglobulins market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Subcutaneous Immunoglobulins market.

Subcutaneous Immunoglobulins Segment by Application

- Primary Immunodeficiency

- Secondary Immunodeficiency

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Subcutaneous Immunoglobulins market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Subcutaneous Immunoglobulins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Subcutaneous Immunoglobulins and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Subcutaneous Immunoglobulins industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Subcutaneous Immunoglobulins

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Subcutaneous Immunoglobulins Product Introduction
1.2 Market by Purity
1.2.1 Global Subcutaneous Immunoglobulins Market Size Growth Rate by Purity (2017 VS 2021 VS 2028)
1.2.2 0.1
1.2.3 0.2
1.3 Market by Application
1.3.1 Global Subcutaneous Immunoglobulins Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Subcutaneous Immunoglobulins Market Size Estimates and Forecasts
2.1.1 Global Subcutaneous Immunoglobulins Revenue 2017-2028
2.1.2 Global Subcutaneous Immunoglobulins Sales 2017-2028
2.2 Subcutaneous Immunoglobulins Market Size by Region: 2022 Versus 2028
2.3 Subcutaneous Immunoglobulins Sales by Region (2017-2028)
2.3.1 Global Subcutaneous Immunoglobulins Sales by Region: 2017-2022
2.3.2 Global Subcutaneous Immunoglobulins Sales Forecast by Region (2023-2028)
2.3.3 Global Subcutaneous Immunoglobulins Sales Market Share by Region (2017-2028)
2.4 Subcutaneous Immunoglobulins Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Subcutaneous Immunoglobulins Revenue by Region: 2017-2022
2.4.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Region (2023-2028)
2.4.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2017-2028)
3 Global Subcutaneous Immunoglobulins by Manufacturers
3.1 Global Top Subcutaneous Immunoglobulins Manufacturers by Sales
3.1.1 Global Subcutaneous Immunoglobulins Sales by Manufacturer (2017-2022)
3.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Subcutaneous Immunoglobulins Manufacturers by Revenue
3.2.1 Global Subcutaneous Immunoglobulins Revenue by Manufacturer (2017-2022)
3.2.2 Global Subcutaneous Immunoglobulins Revenue Share by Manufacturer (2017-2022)
3.3 Global Subcutaneous Immunoglobulins Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Subcutaneous Immunoglobulins Manufacturers Covered: Ranking by Revenue
3.4.2 Global Subcutaneous Immunoglobulins Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Subcutaneous Immunoglobulins Manufacturing Base Distribution, Product Type
3.5.1 Subcutaneous Immunoglobulins Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Subcutaneous Immunoglobulins Product Type
3.5.3 Date of International Manufacturers Enter into Subcutaneous Immunoglobulins Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Shire (Baxalta)
4.1.1 Shire (Baxalta) Corporation Information
4.1.2 Shire (Baxalta) Description, Business Overview
4.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Products Offered
4.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Shire (Baxalta) Subcutaneous Immunoglobulins Sales by Product in 2021
4.1.6 Shire (Baxalta) Subcutaneous Immunoglobulins Sales by Application in 2021
4.1.7 Shire (Baxalta) Subcutaneous Immunoglobulins Sales by Geographic Area in 2021
4.1.8 Shire (Baxalta) Recent Developments
4.2 Grifols
4.2.1 Grifols Corporation Information
4.2.2 Grifols Description, Business Overview
4.2.3 Grifols Subcutaneous Immunoglobulins Products Offered
4.2.4 Grifols Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Grifols Subcutaneous Immunoglobulins Sales by Product in 2021
4.2.6 Grifols Subcutaneous Immunoglobulins Sales by Application in 2021
4.2.7 Grifols Subcutaneous Immunoglobulins Sales by Geographic Area in 2021
4.2.8 Grifols Recent Developments
4.3 CSL
4.3.1 CSL Corporation Information
4.3.2 CSL Description, Business Overview
4.3.3 CSL Subcutaneous Immunoglobulins Products Offered
4.3.4 CSL Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2017-2022)
4.3.5 CSL Subcutaneous Immunoglobulins Sales by Product in 2021
4.3.6 CSL Subcutaneous Immunoglobulins Sales by Application in 2021
4.3.7 CSL Subcutaneous Immunoglobulins Sales by Geographic Area in 2021
4.3.8 CSL Recent Developments
5 Breakdown Data by Purity
5.1 Global Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
5.1.1 Global Subcutaneous Immunoglobulins Sales by Purity (2017-2022)
5.1.2 Global Subcutaneous Immunoglobulins Sales Forecast by Purity (2023-2028)
5.1.3 Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2028)
5.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Purity (2017-2028)
5.2.1 Global Subcutaneous Immunoglobulins Revenue by Purity (2017-2022)
5.2.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Purity (2023-2028)
5.2.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2017-2028)
5.3 Subcutaneous Immunoglobulins Average Selling Price (ASP) by Purity (2017-2028)
6 Breakdown Data by Application
6.1 Global Subcutaneous Immunoglobulins Sales by Application (2017-2028)
6.1.1 Global Subcutaneous Immunoglobulins Sales by Application (2017-2022)
6.1.2 Global Subcutaneous Immunoglobulins Sales Forecast by Application (2023-2028)
6.1.3 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2028)
6.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Application (2017-2028)
6.2.1 Global Subcutaneous Immunoglobulins Revenue by Application (2017-2022)
6.2.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Application (2023-2028)
6.2.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2017-2028)
6.3 Subcutaneous Immunoglobulins Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Subcutaneous Immunoglobulins Market Size YoY Growth 2017-2028
7.2 North America Subcutaneous Immunoglobulins Market Facts & Figures by Country
7.2.1 North America Subcutaneous Immunoglobulins Sales by Country (2017-2028)
7.2.2 North America Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
7.3 North America Subcutaneous Immunoglobulins Sales by Purity
7.4 North America Subcutaneous Immunoglobulins Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Subcutaneous Immunoglobulins Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Subcutaneous Immunoglobulins Market Facts & Figures by Region
8.2.1 Asia-Pacific Subcutaneous Immunoglobulins Sales by Region (2017-2028)
8.2.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue by Region (2017-2028)
8.3 Asia-Pacific Subcutaneous Immunoglobulins Sales by Purity
8.4 Asia-Pacific Subcutaneous Immunoglobulins Sales by Application
9 Europe
9.1 Europe Subcutaneous Immunoglobulins Market Size YoY Growth 2017-2028
9.2 Europe Subcutaneous Immunoglobulins Market Facts & Figures by Country
9.2.1 Europe Subcutaneous Immunoglobulins Sales by Country (2017-2028)
9.2.2 Europe Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
9.3 Europe Subcutaneous Immunoglobulins Sales by Purity
9.4 Europe Subcutaneous Immunoglobulins Sales by Application
10 Latin America
10.1 Latin America Subcutaneous Immunoglobulins Market Size YoY Growth 2017-2028
10.2 Latin America Subcutaneous Immunoglobulins Market Facts & Figures by Country
10.2.1 Latin America Subcutaneous Immunoglobulins Sales by Country (2017-2028)
10.2.2 Latin America Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
10.3 Latin America Subcutaneous Immunoglobulins Sales by Purity
10.4 Latin America Subcutaneous Immunoglobulins Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Subcutaneous Immunoglobulins Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Subcutaneous Immunoglobulins Market Facts & Figures by Country
11.2.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2017-2028)
11.2.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
11.3 Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity
11.4 Middle East and Africa Subcutaneous Immunoglobulins Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Subcutaneous Immunoglobulins Supply Chain Analysis
12.2 Subcutaneous Immunoglobulins Key Raw Materials and Upstream Suppliers
12.3 Subcutaneous Immunoglobulins Clients Analysis
12.4 Subcutaneous Immunoglobulins Sales Channel and Sales Model Analysis
12.4.1 Subcutaneous Immunoglobulins Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Subcutaneous Immunoglobulins Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Subcutaneous Immunoglobulins Distributors
13 Market Dynamics
13.1 Subcutaneous Immunoglobulins Industry Trends
13.2 Subcutaneous Immunoglobulins Market Drivers
13.3 Subcutaneous Immunoglobulins Market Challenges
13.4 Subcutaneous Immunoglobulins Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Subcutaneous Immunoglobulins Market Size Growth Rate by Purity (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of 0.1
Table 3. Major Manufacturers of 0.2
Table 4. Global Subcutaneous Immunoglobulins Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Subcutaneous Immunoglobulins Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 6. Global Subcutaneous Immunoglobulins Sales by Region (2017-2022) & (K Bottle)
Table 7. Global Subcutaneous Immunoglobulins Sales Forecast by Region (2023-2028) & (K Bottle)
Table 8. Global Subcutaneous Immunoglobulins Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Subcutaneous Immunoglobulins Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Global Subcutaneous Immunoglobulins Sales by Manufacturer (2017-2022) & (K Bottle)
Table 11. Global Subcutaneous Immunoglobulins Sales Share by Manufacturer (2017-2022)
Table 12. Subcutaneous Immunoglobulins Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 13. Subcutaneous Immunoglobulins Revenue Share by Manufacturer (2017-2022)
Table 14. Key Manufacturers Subcutaneous Immunoglobulins Price (2017-2022) & (USD/Bottle)
Table 15. Ranking of Global Top Subcutaneous Immunoglobulins Manufacturers by Revenue (US$ Million) in 2021
Table 16. Global Subcutaneous Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 17. Global Subcutaneous Immunoglobulins by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Subcutaneous Immunoglobulins as of 2021)
Table 18. Subcutaneous Immunoglobulins Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Subcutaneous Immunoglobulins Product Type
Table 20. Date of International Manufacturers Enter into Subcutaneous Immunoglobulins Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Shire (Baxalta) Corporation Information
Table 23. Shire (Baxalta) Description and Business Overview
Table 24. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 25. Shire (Baxalta) Subcutaneous Immunoglobulins Product
Table 26. Shire (Baxalta) Subcutaneous Immunoglobulins Sales Proportion of Subcutaneous Immunoglobulins by Product in 2021
Table 27. Shire (Baxalta) Subcutaneous Immunoglobulins Sales Proportion of Subcutaneous Immunoglobulins by Application in 2021
Table 28. Shire (Baxalta) Subcutaneous Immunoglobulins Sales Proportion of Subcutaneous Immunoglobulins by Geographic Area in 2021
Table 29. Shire (Baxalta) Recent Development
Table 30. Grifols Corporation Information
Table 31. Grifols Description and Business Overview
Table 32. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 33. Grifols Subcutaneous Immunoglobulins Product
Table 34. Grifols Subcutaneous Immunoglobulins Sales Proportion of Subcutaneous Immunoglobulins by Product in 2021
Table 35. Grifols Subcutaneous Immunoglobulins Sales Proportion of Subcutaneous Immunoglobulins by Application in 2021
Table 36. Grifols Subcutaneous Immunoglobulins Sales Proportion of Subcutaneous Immunoglobulins by Geographic Area in 2021
Table 37. Grifols Recent Development
Table 38. CSL Corporation Information
Table 39. CSL Description and Business Overview
Table 40. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 41. CSL Subcutaneous Immunoglobulins Product
Table 42. CSL Subcutaneous Immunoglobulins Sales Proportion of Subcutaneous Immunoglobulins by Product in 2021
Table 43. CSL Subcutaneous Immunoglobulins Sales Proportion of Subcutaneous Immunoglobulins by Application in 2021
Table 44. CSL Subcutaneous Immunoglobulins Sales Proportion of Subcutaneous Immunoglobulins by Geographic Area in 2021
Table 45. CSL Recent Development
Table 46. Global Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
Table 47. Global Subcutaneous Immunoglobulins Sales Forecast by Purity (2023-2028) & (K Bottle)
Table 48. Global Subcutaneous Immunoglobulins Revenue by Purity (2017-2022) & (US$ Million)
Table 49. Global Subcutaneous Immunoglobulins Revenue Forecast by Purity (2023-2028) & (US$ Million)
Table 50. Global Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
Table 51. Global Subcutaneous Immunoglobulins Sales Forecast by Application (2023-2028) & (K Bottle)
Table 52. Global Subcutaneous Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
Table 53. Global Subcutaneous Immunoglobulins Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 54. North America Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle)
Table 55. North America Subcutaneous Immunoglobulins Sales by Country (2023-2028) & (K Bottle)
Table 56. North America Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Subcutaneous Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
Table 58. North America Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
Table 59. North America Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
Table 60. Asia-Pacific Subcutaneous Immunoglobulins Sales by Region (2017-2022) & (K Bottle)
Table 61. Asia-Pacific Subcutaneous Immunoglobulins Sales by Region (2023-2028) & (K Bottle)
Table 62. Asia-Pacific Subcutaneous Immunoglobulins Revenue by Region (2017-2028) & (US$ Million)
Table 63. Asia-Pacific Subcutaneous Immunoglobulins Revenue by Region (2023-2028) & (US$ Million)
Table 64. Asia-Pacific Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
Table 65. Asia-Pacific Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
Table 66. Europe Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle)
Table 67. Europe Subcutaneous Immunoglobulins Sales by Country (2023-2028) & (K Bottle)
Table 68. Europe Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Subcutaneous Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
Table 70. Europe Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
Table 71. Europe Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
Table 72. Latin America Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle)
Table 73. Latin America Subcutaneous Immunoglobulins Sales by Country (2023-2028) & (K Bottle)
Table 74. Latin America Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
Table 75. Latin America Subcutaneous Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
Table 76. Latin America Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
Table 77. Latin America Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
Table 78. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle)
Table 79. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2023-2028) & (K Bottle)
Table 80. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
Table 81. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
Table 82. Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
Table 83. Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
Table 84. Subcutaneous Immunoglobulins Key Raw Materials, Industry Status and Trend
Table 85. Subcutaneous Immunoglobulins Key Raw Materials and Upstream Suppliers
Table 86. Subcutaneous Immunoglobulins Clients Status and Trend
Table 87. Subcutaneous Immunoglobulins Typical Clients
Table 88. Subcutaneous Immunoglobulins Distributors
Table 89. Subcutaneous Immunoglobulins Market Trends
Table 90. Subcutaneous Immunoglobulins Market Drivers
Table 91. Subcutaneous Immunoglobulins Market Challenges
Table 92. Subcutaneous Immunoglobulins Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Subcutaneous Immunoglobulins Product Picture
Figure 2. Global Subcutaneous Immunoglobulins Sales Market Share by Purity in 2021 & 2028
Figure 3. 0.1 Product Picture
Figure 4. 0.2 Product Picture
Figure 5. Global Subcutaneous Immunoglobulins Sales Market Share by Application in 2021 & 2028
Figure 6. Primary Immunodeficiency Examples
Figure 7. Secondary Immunodeficiency Examples
Figure 8. Others Examples
Figure 9. Subcutaneous Immunoglobulins Report Years Considered
Figure 10. Global Subcutaneous Immunoglobulins Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Subcutaneous Immunoglobulins Market Size 2017-2028 (US$ Million)
Figure 12. Global Subcutaneous Immunoglobulins Sales 2017-2028 (K Bottle)
Figure 13. Global Subcutaneous Immunoglobulins Market Size Market Share by Region: 2022 Versus 2028
Figure 14. Global Subcutaneous Immunoglobulins Sales Market Share Forecast by Region (2017-2028)
Figure 15. Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2017-2028)
Figure 16. Global Subcutaneous Immunoglobulins Sales Share by Manufacturer in 2021
Figure 17. Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Subcutaneous Immunoglobulins Sales Market Share Forecast by Purity (2017-2028)
Figure 19. Global Subcutaneous Immunoglobulins Revenue Market Share Forecast by Purity (2017-2028)
Figure 20. Subcutaneous Immunoglobulins Average Selling Price (ASP) by Purity (2017-2022) & (USD/Bottle)
Figure 21. Global Subcutaneous Immunoglobulins Sales Market Share Forecast by Application (2017-2028)
Figure 22. Global Subcutaneous Immunoglobulins Revenue Market Share Forecast by Application (2017-2028)
Figure 23. Subcutaneous Immunoglobulins Average Selling Price (ASP) by Application (2017-2022) & (USD/Bottle)
Figure 24. North America Subcutaneous Immunoglobulins Revenue 2017-2028 (US$ Million)
Figure 25. North America Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2022)
Figure 26. North America Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2022)
Figure 27. Asia-Pacific Subcutaneous Immunoglobulins Revenue 2017-2028 (US$ Million)
Figure 28. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Region (2017-2028)
Figure 29. Asia-Pacific Subcutaneous Immunoglobulins Revenue Market Share by Region (2017-2028)
Figure 30. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2022)
Figure 31. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2022)
Figure 32. Europe Subcutaneous Immunoglobulins Revenue Growth Rate 2017-2028 (US$ Million)
Figure 33. Europe Subcutaneous Immunoglobulins Sales Market Share by Country (2017-2028)
Figure 34. Europe Subcutaneous Immunoglobulins Revenue Market Share by Country (2017-2028)
Figure 35. Europe Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2022)
Figure 36. Europe Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2022)
Figure 37. Latin America Subcutaneous Immunoglobulins Revenue Growth Rate 2017-2028 (US$ Million)
Figure 38. Latin America Subcutaneous Immunoglobulins Sales Market Share by Country (2017-2028)
Figure 39. Latin America Subcutaneous Immunoglobulins Revenue Market Share by Country (2017-2022)
Figure 40. Latin America Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2022)
Figure 41. Latin America Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2022)
Figure 42. Middle East and Africa Subcutaneous Immunoglobulins Revenue Growth Rate 2017-2028 (US$ Million)
Figure 43. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Country (2017-2028)
Figure 44. Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Country (2017-2028)
Figure 45. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2022)
Figure 46. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2022)
Figure 47. Subcutaneous Immunoglobulins Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Subcutaneous Immunoglobulins Raw Materials by Region in 2021
Figure 49. Subcutaneous Immunoglobulins Distribution Channels
Figure 50. Global Subcutaneous Immunoglobulins Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 51. Global Subcutaneous Immunoglobulins Percentage 2017-2028: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs